Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
28.84
-0.26 (-0.89%)
At close: Oct 16, 2026, 4:00 PM EDT
28.37
-0.47 (-1.64%)
After-hours: Oct 16, 2026, 7:58 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.62 billion as of October 16, 2026. It is the 4,525th most valuable company in the world and the 1,361st biggest in the United States. Its market cap has increased by 39.67% in one year.
Market Cap
3.62B
Enterprise Value
3.50B
1-Year Change
39.67%
Global Rank
Country Rank
#1,361 United States
Category
ChartMarket Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.62B, an increase of 363.20%. That is a compound annual growth rate of 25.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 3.62B | 1.83% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 3.74B |
| Legend Biotech | 3.73B |
| Tango Therapeutics | 3.67B |
| Telix Pharmaceuticals | 3.53B |
| Acadia Pharmaceuticals | 3.30B |
| Xenon Pharmaceuticals | 3.28B |
| IDEAYA Biosciences | 3.27B |
| Parabilis Medicines | 3.25B |